Literature DB >> 4541036

Mechanisms of immunosuppression: effects of cyclophosphamide on cellular immunity.

A Winkelstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4541036

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  20 in total

1.  Induction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

2.  Effects of 3,3',4,4'-tetrachloroazoxybenzene on selected immune parameters of the mouse.

Authors:  M R Bleavins; R D Hinsdill; J R Hochstein; M T Hsia
Journal:  Arch Environ Contam Toxicol       Date:  1985-11       Impact factor: 2.804

3.  Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

Authors:  J E Balow; D L Hurley; A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 4.  Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.

Authors:  Sonia Tusell Wennier; Jia Liu; Grant McFadden
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

5.  Leukocyte migration inhibition in chorioretinitis.

Authors:  W L Henley; I H Leopold; S Okas
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

6.  Stimulated autoantibody response and increased longevity in NZB/NZW mice treated with cyclophosphamide and tilorone.

Authors:  S E Walker; M R Anver
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

7.  Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.

Authors:  T Maeda; M Eto; Y Nishimura; K Nomoto; Y Y Kong; K Nomoto
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

8.  NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

Authors:  Antonio Russo; Giacomo Oliveira; Sofia Berglund; Raffaella Greco; Valentina Gambacorta; Nicoletta Cieri; Cristina Toffalori; Laura Zito; Francesca Lorentino; Simona Piemontese; Mara Morelli; Fabio Giglio; Andrea Assanelli; Maria Teresa Lupo Stanghellini; Chiara Bonini; Jacopo Peccatori; Fabio Ciceri; Leo Luznik; Luca Vago
Journal:  Blood       Date:  2017-10-06       Impact factor: 22.113

9.  Differential effects of immunosuppressants on lymphocyte function.

Authors:  A Winkelstein
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

10.  In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets.

Authors:  S Peppoloni; B J Mathieson; R B Herberman; R W Overton; E Gorelik
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.